Scarica l'app Stockscreener
617.15
0.58%
-3.57
Pre-mercato:
612.60
-4.55
-0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$620.72
Aprire:
$618.7
Volume 24 ore:
2.40M
Relative Volume:
1.38
Capitalizzazione di mercato:
$231.87B
Reddito:
$43.74B
Utile/perdita netta:
$6.58B
Rapporto P/E:
35.66
EPS:
17.3072
Flusso di cassa netto:
$6.11B
1 W Prestazione:
+6.51%
1M Prestazione:
+7.75%
6M Prestazione:
+47.40%
1 anno Prestazione:
+13.10%
Intervallo 1D:
$614.72
$626.77
Intervallo di 1 settimana:
$577.00
$628.08
Portata 52W:
$385.46
$628.08
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Confronta TMO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
$43.36 Bn Autism Spectrum Disorder Diagnostics Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F - GlobeNewswire Inc.
How The Narrative Around Thermo Fisher Scientific (TMO) Is Shifting After Q3 And New Forecasts - Yahoo Finance
Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings - TechStock²
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings - TechStock²
Thermo Fisher Scientific Builds Hub to Support Local Life Sciences Companies - PHILADELPHIA.Today
The Truth About Thermo Fisher Scientific (TMO): Quiet Lab Giant, Loud Stock Moves - AD HOC NEWS
Thermo Fisher launches obesity registry to track real-world treatment outcomes - drugdiscoverytrends.com
Strategy To YieldBoost Thermo Fisher Scientific To 3.1% Using Options - Nasdaq
Thermo Fisher Scientific (TMO) Valuation Check As New Obesity Registry And Key Updates Draw Investor Focus - Yahoo Finance
Thermo Fisher Scientific to Acquire Clario in $8.875 Billion Deal, Strengthening Digital Clinical Research Capabilities - eHealth Magazine
Bovine Serum Albumin Market to hit US$ 30.89 Billion by 2032 | Top - openPR.com
Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector: Empowering every lab to protect what matters most - Innovation News Network
Is Thermo Fisher (TMO) Using Clario And Margin Focus To Quietly Redefine Its Pharma Toolkit? - simplywall.st
Thermo Fisher Scientific stock hits a 52-week high as Evercore lifts target and obesity registry launch draws focus - TechStock²
Thermo Fisher stock closes higher near 52-week high as January data, earnings loom - ts2.tech
Thermo Fisher Scientific Stock: Quiet Grind Higher Tests Investors’ Patience - AD HOC NEWS
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Finviz
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference - pharmiweb.com
Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - sharewise.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treat - PharmiWeb.com
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes - BioSpace
What to expect from Thermo Fisher Scientific's next quarterly earnings report - MSN
Robeco Institutional Asset Management B.V. Buys 233,200 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
The Truth About Thermo Fisher Sci.: Why Wall Street Is Quietly Obsessing - AD HOC NEWS
Thermo Fisher Scientific: Quiet Rally Or Calm Before The Next Storm? - AD HOC NEWS
Thermo Fisher Scientific enrols first patient in the new PPD CorEvitas Alzheimer’s Disease Registry - Select Science
Thermo Fisher stock closes at a 52-week high after Evercore target raise — what to watch next for TMO - ts2.tech
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week HighShould You Buy? - MarketBeat
Thermo Fisher Scientific stock reaches 52-week high at $610.97 By Investing.com - Investing.com Nigeria
Thermo Fisher Scientific stock reaches 52-week high at $610.97 - Investing.com
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus - TechStock²
Unpleasant Surprises Could Be In Store For Thermo Fisher Scientific Inc.'s (NYSE:TMO) Shares - simplywall.st
Thermo Fisher Scientific wins three R&D 100 Awards for innovations accelerating drug development - R&D World
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $650 From $610, Maintains Outperform Rating - MarketScreener
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance
14,819 Shares in Thermo Fisher Scientific Inc. $TMO Bought by Greystone Financial Group LLC - MarketBeat
Railway Pension Investments Ltd Increases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Clinical Trial Supplies Company Evaluation Report 2025: Market Led by Thermo Fisher Scientific, Sharp Services, and Parexel Through End-to-End Capabilities Span Packaging, Logistics, Trial ManagementResearchAndMarkets.com - FinancialContent
Cynosure Group LLC Sells 5,293 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
HD Automatic Colony Counter Market Is Going to Boom |• Thermo Fisher Scientific • Beckman Coulter - openPR.com
Thermo Fisher (TMO) stock closes higher into 2026 — what to watch before Jan. 29 earnings - ts2.tech
North Growth Management Ltd. Purchases 6,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by GAM Holding AG - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Asset Management One Co. Ltd. - MarketBeat
Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings? - Finviz
Thermo Fisher (TMO) stock rises 2% to start 2026 as earnings, key data loom - ts2.tech
Synergy Asset Management LLC Has $3.41 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
Altfest L J & Co. Inc. Buys Shares of 5,883 Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher stock jumps 2% to start 2026 as investors turn to Jan. 29 earnings - ts2.tech
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):